Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Apellis Pharmaceuticals Inc. (APLS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Farallon Capital

Thomas Steyer

2,250,000 $73,485 +13% 0.6%
2. 2,066,108 $67,479 -9% 2.57%
3. 1,369,760 $44,737 +87% 0.01%
4.
Millennium Management

Israel Englander

1,075,250 $35,118 -21% 0.04%
5.
Two Sigma Advisors

John Overdeck And David Siegel

921,200 $30,086 +6% 0.08%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$31.81 5,000 Director 5,000 2020-05-08 Filing
$37.00 540,540 Large Shareholder 12,556,342 2020-01-13 Filing
$29.71 11,699 Officer 11,699 2019-08-29 Filing
$17.00 441,176 Large Shareholder 12,015,802 2019-03-11 Filing
$19.84 40,000 Large Shareholder 11,574,626 2018-09-21 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$26.28 600 Officer 29,525 2020-08-03 Filing
$32.12 5,000 Officer, Director 1,098,079 2020-07-15 Filing
$32.43 850 Officer 30,125 2020-07-01 Filing
$30.21 856 Officer 30,975 2020-06-15 Filing
$30.21 2,500 Director 669,544 2020-06-15 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 10,444,511 $341,118 0.07%
2. 7,294 $238,222 0%
3. 4,388,181 $143,318 0%
4. 2,946,814 $96,243 0%
5. 2,127,078 $69,470 0.06%
News See All